Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VMDthis companyViemed Healthcare, Inc.	$8.85	19.55×	2.04×	1.07×	5.65×	-98.4%	57.5%	7.7%	5.5%	10.6%	8.3%	4.1%	0.11×	0.05×	17.52×	1.18×	0.0%	6	6.34	3	B+
CVRXCVRx, Inc.	$0.82	-3.48×	4.71×	3.27×	-3.43×	-11723.2%	85.3%	-90.5%	-94.1%	-135.6%	-56.0%	-22.0%	1.29×	0.53×	-8.8×	7.63×	0.0%	3	-9.03	1	D+
ELMDElectromed, Inc.	$27.17	30.88×	6.48×	4.74×	22.02×	-45.6%	78.5%	18.8%	15.3%	20.9%	20.2%	2.4%	0×	-1.36×	0×	4.69×	0.0%	7	14.18	4	A
INGNInogen, Inc.	$5.92	-7.91×	0.95×	0.52×	-35.43×	-203.4%	47.6%	-8.7%	-6.5%	-11.8%	-12.3%	-11.8%	0.09×	31.71×	0×	3.12×	0.0%	3	1.53	2	C
MASS908 Devices Inc.	$11.35	-5.2×	1.32×	3.38×	-3.25×	-184.4%	47.7%	-43.0%	-65.2%	-25.5%	-14.0%	-13.0%	0.12×	3.33×	0×	4.24×	0.0%	3	2.13	2	C
OMOutset Medical, Inc.	$4.37	-0.69×	0.44×	0.47×	-1.97×	-1772.3%	39.1%	-55.8%	-68.3%	-64.3%	-29.2%	-83.5%	0.8×	-1.06×	-4.78×	6.67×	0.0%	3	-6.08	2	C
Peer median	—	-3.48×	1.32×	3.27×	-3.25×	-203.4%	47.7%	-43.0%	-65.2%	-25.5%	-14.0%	-13.0%	0.12×	0.53×	0×	4.69×	0.0%	3	1.53	2	—